BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 10 filers reported holding BIO BLAST PHARMA LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $8,000 | -27.3% | 13,100 | -8.4% | 0.00% | – |
| Q1 2017 | $11,000 | -57.7% | 14,300 | -42.1% | 0.00% | -100.0% |
| Q4 2016 | $26,000 | -64.4% | 24,700 | -42.2% | 0.00% | -50.0% |
| Q3 2016 | $73,000 | -11.0% | 42,700 | -17.2% | 0.00% | 0.0% |
| Q2 2016 | $82,000 | -47.1% | 51,600 | -17.4% | 0.00% | -60.0% |
| Q1 2016 | $155,000 | -49.2% | 62,465 | -20.8% | 0.01% | -44.4% |
| Q4 2015 | $305,000 | -20.6% | 78,870 | +4.6% | 0.01% | -25.0% |
| Q3 2015 | $384,000 | -21.6% | 75,395 | +6.0% | 0.01% | -14.3% |
| Q2 2015 | $490,000 | +62.8% | 71,147 | +41.8% | 0.01% | +75.0% |
| Q1 2015 | $301,000 | +189.4% | 50,160 | +207.7% | 0.01% | +166.7% |
| Q4 2014 | $104,000 | – | 16,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 250,970 | $625,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 1,133,937 | $2,824,000 | 0.14% |
| Visium Asset Management, LP | 713,625 | $1,777,000 | 0.03% |
| OPPENHEIMER & CO INC | 62,465 | $155,000 | 0.01% |
| Virtu KCG Holdings LLC | 21,771 | $54,000 | 0.00% |
| UBS Group AG | 1,698 | $4,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $2,000 | 0.00% |
| MORGAN STANLEY | 25 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 242 | $1,000 | 0.00% |
| HighTower Advisors, LLC | 35,700 | $86,000 | 0.00% |